PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE
 Distribuzione geografica
Continente #
NA - Nord America 8.187
EU - Europa 3.504
AS - Asia 1.063
SA - Sud America 16
AF - Africa 13
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.798
Nazione #
US - Stati Uniti d'America 8.077
IT - Italia 785
DE - Germania 661
CN - Cina 630
IE - Irlanda 510
SE - Svezia 497
UA - Ucraina 290
HK - Hong Kong 180
AT - Austria 179
GB - Regno Unito 169
FR - Francia 105
CA - Canada 102
RU - Federazione Russa 85
FI - Finlandia 80
VN - Vietnam 66
DK - Danimarca 63
IN - India 46
TR - Turchia 42
SG - Singapore 41
NL - Olanda 27
JP - Giappone 23
ES - Italia 17
BE - Belgio 14
ID - Indonesia 14
AU - Australia 7
CH - Svizzera 7
IR - Iran 6
MX - Messico 6
BR - Brasile 5
EU - Europa 5
KR - Corea 5
SA - Arabia Saudita 5
CL - Cile 4
CO - Colombia 3
EG - Egitto 3
PE - Perù 3
PL - Polonia 3
RO - Romania 3
SC - Seychelles 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
HR - Croazia 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BT - Bhutan 1
DZ - Algeria 1
EC - Ecuador 1
ET - Etiopia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PT - Portogallo 1
TW - Taiwan 1
Totale 12.798
Città #
Ann Arbor 2.328
Woodbridge 670
Fairfield 669
Chandler 562
Dublin 493
Houston 475
Wilmington 463
Ashburn 444
Frankfurt am Main 440
Jacksonville 297
Seattle 290
Dearborn 261
New York 231
Cambridge 222
Princeton 194
Hong Kong 178
Vienna 178
Milan 174
Nanjing 139
Lawrence 92
Altamura 91
Beijing 68
San Diego 53
Dong Ket 48
Shanghai 48
Lachine 43
Nanchang 42
Falls Church 37
Guangzhou 36
Boardman 32
Lissone 32
Andover 31
Singapore 31
Shenyang 30
Jinan 29
Tianjin 27
Helsinki 26
Pune 24
London 23
Ottawa 23
Hebei 20
Zhengzhou 19
Changsha 18
Ningbo 18
Rome 17
Kunming 16
Norwalk 16
Toronto 16
Fremont 15
Hangzhou 15
Jiaxing 15
Brussels 14
Jakarta 14
Huizen 13
Redmond 13
Edmonton 12
Kocaeli 12
Auburn Hills 11
Los Angeles 11
Monza 10
Kiev 9
Mountain View 8
Naples 8
Nürnberg 8
San Mateo 8
Taizhou 8
Washington 8
Hefei 7
Leawood 7
Paullo 7
Detroit 6
Duncan 6
Kilburn 6
Montréal 6
Saint Louis 6
Xiamen 6
Bari 5
Chicago 5
Pavia 5
Taiyuan 5
University Park 5
Wuhan 5
Abbiategrasso 4
Arlington 4
Bologna 4
Cernusco sul Naviglio 4
Changchun 4
Chengdu 4
Daejeon 4
Genoa 4
Lanzhou 4
Levate 4
Madrid 4
Melbourne 4
Shenzhen 4
Simi Valley 4
Soresina 4
São Paulo 4
Tokyo 4
Brugherio 3
Totale 10.084
Nome #
Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties 323
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 322
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 298
MALDI imaging in Fabry nephropathy: a multicenter study 289
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 282
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 252
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 247
Microscopic Polyangiitis 246
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 227
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 223
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 219
Kidney Involvement 210
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 209
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 209
The putative role of MALDI-MSI in the study of Membranous Nephropathy 206
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 195
Proteomics for the study of new biomarkers in Fabry disease: State of the art 195
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 183
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 177
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo 175
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 172
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo 168
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 167
Electrophysiological evidence of ipsilateral reno-renal reflexes in the cat 165
A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval 165
Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age 158
Role of fat distribution indicators in the identification of hypertension in children 157
Parapelvic cysts, a distinguishing feature of renal Fabry disease 157
Renal afferents responsive to chemical and mechanical pelvic stimuli in the rabbit 156
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 156
Obesity-associated hypertension in childhood: A new epidemic problem 155
Fusarium solani infection after antimicrobial treatment of a severe bacterial peritonitis: a case report and review of the literature 154
Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure 151
Usefulness of waist circumference for the identification of childhood hypertension 145
Warped-average template technique to track on a cycle-by-cycle basis the cardiac filling phases on left ventricular volume 144
Intrafamilial phenotypic variability in four families with Anderson-Fabry disease 144
New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases 144
FAbry STabilization indEX (FASTEX): An innovative tool for the assessment of clinical stabilization in Fabry disease 143
Renal afferents signaling diuretic activity in the cat 142
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 139
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 136
Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats 134
QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium 133
Angiotensin II increases tissue inhibitor matrix metalloproteinase-2 (TIMP-2) gene expression in rat aorta in vivo 128
Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight 127
ANCA-associated vasculitis in childhood: Recent advances 127
Adrenergic overdrive in mild renal failure: Regional patterns and relationships with metabolic and cardiac abnormalities 126
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 126
Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension 125
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 124
Anticoagulant-related nephropathy: a pathological note 121
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 120
Angiotensin II modulates MMP-2/TIMP-2 gene expression in rat aorta in vivo 118
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 118
Hypertension in childhood: autonomic and metabolic patterns 117
Neuronal nitric oxide synthase and renin stimulation by sodium deprivation are dependent on the renal nerves 116
Possible Pathogenetic Relationship between Fabry Disease and Renal Cell Carcinoma 115
Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy 113
Redefining the pulvinar sign in fabry disease 110
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats 109
Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat 109
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study 108
MALDI imaging mass spectrometry in glomerulonephritis: feasibility test 105
Avacopan for the treatment of ANCA-associated vasculitis 105
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 102
Analysis of heart period and arterial pressure variability in childhood hypertension: key role of baroreflex impairment 100
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial 100
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure 99
Sympathetic activation in cardiovascular and renal disease 98
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells 97
Mutations in the GLA gene and LysoGb3: Is it really Anderson-Fabry disease? 97
Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat 96
[Clinical and histological findings in Fabry nephropathy] 95
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 95
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 90
The children of dialysis: Live-born babies from on-dialysis mothers in Italy - An epidemiological perspective comparing dialysis, kidney transplantation and the overall population 89
Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats 88
Tumour incidence in Fabry disease: A cross-sectional study 86
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease 84
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 82
La diagnosi precoce di malattia 79
La terapia enzimatica sostitutiva nella malattia di Fabry 77
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study 75
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease 74
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 74
Cardiological follow-up in patients with Fabry disease 68
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease 67
Heart involvement in Anderson-Fabry disease: Italian recommendations for diagnostic, follow-up and therapeutic management [Il coinvolgimento cardiaco nella malattia di Anderson-Fabry: Nuove raccomandazioni sulla diagnosi, il follow-up e la terapia] 63
Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders 63
Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease 63
Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy 61
SARS-CoV-2 and Hemodialysis: diffusion and mortality in patients and health care team. Reflections from the Lombardy experience 60
Renal reflexes and denervation in heart failure 54
ECG-based score estimates the probability to detect Fabry Disease cardiac involvement 51
The GALA project: Practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts 45
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2020), 10.1007/s40620-020-00774-5) 41
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 30
Migalastat treatment in a kidney-transplanted patient with fabry disease and n215s mutation: The first case report 28
Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study 23
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148) 21
Totale 13.254
Categoria #
all - tutte 41.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.260


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019307 0 0 0 0 0 0 0 0 0 0 0 307
2019/20202.176 275 131 173 167 185 275 303 162 205 114 147 39
2020/20212.474 126 79 210 228 211 251 278 308 218 215 148 202
2021/20221.614 155 198 187 148 115 140 47 81 73 91 117 262
2022/20232.290 255 725 192 177 154 357 27 115 157 15 55 61
2023/20241.550 56 46 53 81 191 506 288 56 119 31 42 81
Totale 13.344